Africa's Goal of Self-Sufficiency in Healthcare

Following the inequalities experienced during the COVID-19 pandemic, Africa continues its efforts to reduce external dependence and achieve strategic self-sufficiency in vaccine production. While enhancing the resilience of health systems across the continent, new production facilities are being implemented with international funding support.

The Post-Pandemic Need for Healthcare Self-Sufficiency

Drawing on lessons learned during the COVID-19 pandemic, the journey to achieve strategic self-sufficiency in vaccine production and ensure Africa's health security stands out as an urgent necessity. The fact that Africa was left behind during a period when wealthy countries stockpiled medicines makes it imperative to end over-reliance on external resources.

Healthcare Achievements Gained Across the Continent

The progress of the continent was highlighted at the session of the World Health Organization Regional Committee for Africa. Ethiopia bringing the Marburg outbreak under control within 90 days demonstrated national health capacity. Furthermore, more than 18 million children were vaccinated, 21.7 million people received HIV treatment, and the tuberculosis treatment rate rose to 74%.

New Vaccine Manufacturing Facilities and Financial Steps

The $15 million loan agreement signed by the African Development Bank with the South African Biologics and Vaccines Institute brings a new vaccine manufacturing facility project to life. This project marks a significant milestone in the continent's journey to reduce its dependence on imported vaccines.

The 2040 Target and Health Sovereignty Process

The African Union aims to be 60 percent self-sufficient in vaccines for the entire continent by 2040. Despite chronic challenges such as shortages of medical personnel, lack of technical expertise, and the debt burden, efforts for health sovereignty continue.